Issing et al. demonstrated that head and neck cancer organoids can effectively model radiotherapy resistance, showing that HPV infection and TP53 mutations significantly influence the radiation response, with HPV-positive tumors exhibiting greater sensitivity to radiation, while TP53 mutations correlate with increased radioresistance [73]. The gene discussed is TP53; the disease is head and neck cancer.